Skip to main content
Market intelligence
AMRXHealthcare

Amneal Pharmaceuticals Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 13, 2026John KielyCorporate insiderSale50,000$17.64$882,000
Aug 12, 2026Nikita ShahExecutive Vice PresidentSale146,403$17.51$2,563,517
Aug 12, 2026Jason B. DalyEVP, Chief Legal OfficerSale216,613$17.41$3,771,059